Literature DB >> 17347858

Plasma ghrelin response to an oral glucose load in growth hormone-deficient adults treated with growth hormone.

Peter Pusztai1, Judit Toke, Aniko Somogyi, Eva Ruzicska, Beatrix Sarman, Karoly Racz, Zsolt Tulassay.   

Abstract

BACKGROUND: Little is known about the pathophysiology of ghrelin secretion in growth hormone-deficient adults treated with growth hormone, and the relationship between plasma ghrelin and hyperinsulinemia induced by an oral glucose load has not been investigated in these patients.
OBJECTIVE: In the present study we examined the relationship between plasma ghrelin, insulin, C-peptide and leptin after an oral glucose load in growth hormone-deficient adults receiving treatment with growth hormone.
METHODS: Plasma ghrelin, leptin, insulin, C-peptide and blood glucose were measured before and then at 30, 60, 90 and 120 min after the ingestion of glucose (75 g orally) in 20 growth hormone-deficient adults (12 women and 8 men), who had been treated with growth hormone for 7.2 +/- 1.3 years (mean +/- SE). Plasma ghrelin was also determined before and after the glucose load in 10 age-and weight-matched healthy persons (5 women and 5 men).
RESULTS: The oral glucose load induced a similar percent suppression of plasma ghrelin in the growth hormone-deficient patients and in the healthy persons. In both groups plasma ghrelin decreased significantly 30 min after the glucose load and remained suppressed throughout the test period. In the patients plasma insulin (baseline, 15.9 +/- 3.9 microIU/ml) and C-peptide (baseline, 2.5 +/- 0.3 ng/ml) showed opposite changes with peak responses at 30 min (insulin, 109.5 +/- 15.6 microIU/ml) or 60 min (C-peptide, 10.3 +/- 1.1 ng/ml). In these patients, post-glucose, but not baseline plasma ghrelin levels correlated negatively with plasma insulin, C-peptide and blood glucose levels, whereas baseline plasma ghrelin correlated inversely with baseline plasma leptin.
CONCLUSIONS: The similar suppression of plasma ghrelin in growth hormone-deficient patients treated with growth hormone and in healthy persons after an oral glucose load argues against disturbed regulation of ghrelin secretion in these patients. The correlations between post-glucose plasma ghrelin, insulin and blood glucose support the existence of a previously proposed link between hyperinsulinemia (or increased blood glucose) and suppression of ghrelin levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17347858     DOI: 10.1007/s00508-006-0743-6

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  25 in total

1.  Characterization of leptin pulse dynamics and relationship to fat mass, growth hormone, cortisol, and insulin.

Authors:  Polyxeni Koutkia; Bridget Canavan; Michael L Johnson; Alex DePaoli; Steven Grinspoon
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-04-29       Impact factor: 4.310

2.  Ghrelin suppression in overweight children: a manifestation of insulin resistance?

Authors:  Fida Bacha; Silva A Arslanian
Journal:  J Clin Endocrinol Metab       Date:  2005-02-22       Impact factor: 5.958

3.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.

Authors:  D E Cummings; J Q Purnell; R S Frayo; K Schmidova; B E Wisse; D S Weigle
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

4.  Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy.

Authors:  J A Janssen; F M van der Toorn; L J Hofland; P van Koetsveld; F Broglio; E Ghigo; S W Lamberts; A Jan van der Lely
Journal:  Eur J Endocrinol       Date:  2001-12       Impact factor: 6.664

5.  Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans.

Authors:  Y Date; M Kojima; H Hosoda; A Sawaguchi; M S Mondal; T Suganuma; S Matsukura; K Kangawa; M Nakazato
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

6.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

7.  Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes.

Authors:  Seppo M Pöykkö; Eija Kellokoski; Sohvi Hörkkö; Heikki Kauma; Y Antero Kesäniemi; Olavi Ukkola
Journal:  Diabetes       Date:  2003-10       Impact factor: 9.461

8.  Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans.

Authors:  Jonathan Q Purnell; David S Weigle; Patricia Breen; David E Cummings
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

9.  Food fails to suppress ghrelin levels in obese humans.

Authors:  P J English; M A Ghatei; I A Malik; S R Bloom; J P H Wilding
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

10.  Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients.

Authors:  Vincenzo Cappiello; Cristina Ronchi; Paola S Morpurgo; Paolo Epaminonda; Maura Arosio; Paolo Beck-Peccoz; Anna Spada
Journal:  Eur J Endocrinol       Date:  2002-08       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.